Home » Authors » Brady Huggett

Articles by Brady Huggett

Indevus' Trospium Phase III Hits Primary, Secondary Endpoints

Sep. 25, 2002

By Brady Huggett

Indevus' Trospium Phase III Hits Primary, Secondary Endpoints

Sep. 25, 2002

By Brady Huggett

Kosan Signs $220M Deal With Roche For KOS-862 Cancer Drug

Sep. 24, 2002

By Brady Huggett

Kosan Signs $220M Deal With Roche For KOS-862 Cancer Drug

Sep. 24, 2002

By Brady Huggett

CellGate Closes $10M Series D, Aims For 2003 PsorBan Phase III

Sep. 23, 2002

By Brady Huggett

Bio-Technology General To Buy Rosemont For $99M In Cash

Sep. 23, 2002

By Brady Huggett

CombinatoRx Raises $40M In Series C To Fund Clinical Trials

Sep. 23, 2002

By Brady Huggett

CellGate Closes $10M Series D, Aims For 2003 PsorBan Phase III

Sep. 23, 2002

By Brady Huggett

CombinatoRx Raises $40M In Series C To Fund Clinical Trials

Sep. 23, 2002

By Brady Huggett

Bio-Technology General To Buy Rosemont For $99M In Cash

Sep. 23, 2002

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...